Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020.

COVID-19 Japan SARS-CoV-2 coronavirus disease cruise ship epidemiology outbreak respiratory infections severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 1 9 2021
Statut: ppublish

Résumé

In April 2020, a coronavirus disease (COVID-19) outbreak occurred on the cruise ship Costa Atlantica in Nagasaki, Japan. Our outbreak investigation included 623 multinational crewmembers onboard on April 20. Median age was 31 years; 84% were men. Each crewmember was isolated or quarantined in a single room inside the ship, and monitoring of health status was supported by a remote health monitoring system. Crewmembers with more severe illness were hospitalized. The investigation found that the outbreak started in late March and peaked in late April, resulting in 149 laboratory-confirmed and 107 probable cases of infection with severe acute respiratory syndrome coronavirus 2. Six case-patients were hospitalized for COVID-19 pneumonia, including 1 in severe condition and 2 who required oxygen administration, but no deaths occurred. Although the virus can spread rapidly on a cruise ship, we describe how prompt isolation and quarantine combined with a sensitive syndromic surveillance system can control a COVID-19 outbreak.

Identifiants

pubmed: 34423761
doi: 10.3201/eid2709.204596
pmc: PMC8386778
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2251-2260

Références

Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
J Travel Med. 2021 Feb 23;28(2):
pubmed: 32901817
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-352
pubmed: 32214086
N Engl J Med. 2020 Aug 27;383(9):885-886
pubmed: 32530584
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Clin Microbiol Infect. 2020 Jun;26(6):773-779
pubmed: 32276116
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Emerg Infect Dis. 2020 Nov;26(11):2591-2597
pubmed: 32822290
J Mol Diagn. 2020 Jun;22(6):729-735
pubmed: 32276051
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553062
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Jpn J Infect Dis. 2020 Nov 24;73(6):491-493
pubmed: 32611985
Lancet Infect Dis. 2020 Sep;20(9):1043-1050
pubmed: 32539988
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Travel Med. 2020 May 18;27(3):
pubmed: 32109273
Nature. 2020 Apr;580(7801):18
pubmed: 32218546
Mol Med Rep. 2020 Jul;22(1):9-19
pubmed: 32377709
Disaster Med Public Health Prep. 2020 Aug;14(4):506-513
pubmed: 32207674
PLoS Negl Trop Dis. 2020 Nov 4;14(11):e0008855
pubmed: 33147214
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32521222
Acute Med Surg. 2020 Mar 24;7(1):e506
pubmed: 32313661

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH